🔗 Share this article

Chancellor Reeves has stated she is planning "targeted steps to deal with household expense pressures" in next month's financial statement.

During an interview with media outlets, she noted that lowering price rises is a shared duty of both the administration and the Bank of England.

The UK's price growth is projected to be the highest among the Group of Seven industrialized countries this calendar year and the following year.

Potential Energy Bill Measures

Sources suggest the administration could take action to bring down energy bills, for instance by reducing the current 5% rate of value-added tax applied on energy supplies.

An additional possibility is to cut some of the policy costs currently included in household expenses.

Fiscal Limitations and Analyst Expectations

The administration will receive the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will show how much room there is for such actions.

The consensus from most experts is that the Chancellor will have to declare tax increases or budget cuts in order to fulfill her voluntary borrowing rules.

Earlier on the same day, calculations suggested there was a £22bn gap for the chancellor to fill, which is at the more modest range of projections.

"There's a shared job between the central bank and the government to continue tackling some of the drivers of price increases," Reeves informed the BBC in Washington, at the conferences of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Issues

While much of the focus has been on likely tax rises, the Treasury chief said the most recent data from the OBR had not changed her commitment to manifesto promises not to increase rates on earnings tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with rising geopolitical and commercial tensions for the fiscal revenue measures, likely to be directed on those "with the broadest shoulders."

International Economic Tensions

Referring to concerns about the UK's commercial links with China she said: "Our national security invariably take priority."

Last week's statement by China to tighten export controls on rare earths and other materials that are essential for advanced tech manufacturing led US President the US President to threaten an additional 100% tariff on goods from the Asian country, increasing the possibility of an all-out trade war between the two largest economies.

The US Treasury Secretary called the Chinese move "economic coercion" and "a global supply chain power grab."

Questioned on considering the US offer to participate in its battle with China, the Chancellor said she was "extremely troubled" by China's measures and encouraged the Chinese government "not to put up barriers and limit trade."

She said the decision was "damaging for the world economy and creates additional headwinds."

"In my view there are fields where we should challenge Chinese policies, but there are also significant prospects to sell into Chinese markets, including financial services and other sectors of the economic system. We've got to achieve that balance appropriate."

The chancellor also affirmed she was collaborating with other major economies "regarding our own essential resources approach, so that we are reduced dependence."

Health Service Medicine Costs and Investment

The Chancellor also acknowledged that the price the NHS pays for medicines could increase as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the biggest global drug companies have said lately that they are either halting or canceling projects in the United Kingdom, with some blaming the insufficient payments they are getting.

Last month, the government science advisor said the price the health service spends on medicines would must increase to stop businesses and pharmaceutical investment leaving the UK.

The Chancellor informed the BBC: "It has been observed due to the cost structure, that drug testing, innovative medicines have not been offered in the United Kingdom in the extent that they are in other European countries."

"Our aim is to guarantee that individuals receiving treatment from the National Health Service are able to access the best essential medicines in the world. And so we are examining these issues, and... aiming to secure additional investment into the UK."